Movement on the market reflected at CPhI Worldwide 2018

Companies new to CPhI to showcase an exciting range of products and services ranging from electroceuticals to refrigerant alternatives.
Each year, CPhI Worldwide affords the pharmaceutical industry the opportunity to come together to share and learn. Each year, new exhibitors use the event as a platform to showcase their products and services, which frequently mirror trends in customer demand and regulatory requirements.
FDF
Making the intolerable, tolerable
Anemia is one of the most widespread diseases in the world and more than 50% of the cases are due to iron deficiency. To recover iron deficiency, however, oral iron products are generally problematic for many patients who are unlikely to tolerate iron and, therefore, are forced to drop out the treatment or to resort to complicated, intravenous administration.
Pharmanutra’s SiderAL products, however, are based on patented Sucrosomial Iron and offer higher tolerability and bioavailability compared with traditional iron-based products. Thanks to its unique delivery system, SiderAL is considered by many as the most effective and innovative oral iron supplement on the market.
The SiderAL range of products includes several formulations, developed to comply with the different nutritional requirements for children, men and women, who need to boost their iron status, reduce fatigue and improve their quality of life.
Migraine is an extraordinarily prevalent neurological disease and the third most prevalent illness in the world. For many migraine suffers, current antimigraine drugs are not tolerated or contraindicated.
To fulfil the unmet needs of migraine medications, Cefaly Technology offers an evidence-based e-TNS (external Trigeminal Nerve Stimulation) device indicated to treat and prevent migraine. The device’s efficacy/safety profile is excellent, exceeding many antimigraine medication.
The Cefaly — a battery-powered device applied on the forehead using a self-adhesive electrode positioned bilaterally over the upper branches of the trigeminal nerve — generates precise electrical impulses allowing to stimulate the trigeminal nerve.
ICSE
Outsourcing going green
The destructive effect of chlorofluorocarbon refrigerants on the ozone layer is well known. Concern, however, is not limited to CO2 but includes all fluorinated refrigerants and their global warming potential (GWP).
Many gases generated as the result of human activity are more harmful than CO2. Therefore, a gas’s GWP must also be considered as well as the gas quantity released into the atmosphere. European and national regulations controlling the emission of these gases greatly affect industries requiring freeze drying, as the fluorinated refrigerants used in their thermal systems have a high GWP.
As experts in freeze-drying equipment and associated regulatory requirements, CoolVacuum designs and manufactures freeze dryers for numerous sectors. The company offers customers customized solutions, ranging from developing projects for new processes to improving existing one.
CDMOs are becoming more diverse and innovative in their product and service offerings. In response to current trends in and customer demand for products using ‘natural’ and ‘ethical’ ingredients, Farmaceutici Procemsa has launched the first products developed following a new ‘Green & Tech’ philosophy, which combines the ancient phytotherapeutic tradition with technological innovation.
At this year’s CPhI, the company will be offering for the first time an original proposal in the dermocosmetic sector - an innovative gel cream to treat skin imperfections associated with cellulite. The product, which provides a thermogenic action, contains a complex of an Alfalfa (Medicago sativa) extract titrated in a defined tripeptide combined with melatonin.
InnoPack
Rubber and plastic
Sanok RC is a dynamically developing manufacturer of rubber stoppers for use in pharmacy and veterinary medicine. The excellent quality of rubber compounds can be used in a wide range of applications for different types of preparations — antibiotics, infusion fluids, insulin, blood and blood products, and lyophilization — and are made to GMP white zone standards together with a high level of molecular and microbiological purity.
With an openness to specific customer requirement, the company can execute new projects; that is, the preparation of recipes and the implementation of new structural solutions.
Building on the success of having established long-term co-operative relationships with 50% of the top-100 pharmaceutical manufacturers of mist spray medicines in China, Xinjitai (XJT) has decided the time is right to move beyond its domestic market and showcase its products at CPhI Worldwide.
The company focusses on manufacturing plastic metered mist sprayers (pumps), such as nasal sprayers, throat or oral sprayers, and topical sprayers. Unlike many other suppliers, all XJT sprayers do not contain polyoxymethylene (POM) or rubber; instead, the company uses polypropylene (PP) and polyethylene (PE).



-comp272482.gif)



Related News
-
News CPhI North America Lookahead: Facilitating ‘meaningful conversations’ on needs and solutions
CPhI NA takes place as a SMART event this year, with online learning and networking from May 9-27 and an in-person event from May 17-19 in Philadelphia, PA. -
News Early development demand continues to boost prospects for smaller CDMOs: CPhI Worldwide panel
The increasing outsourcing trend among pharmaceutical companies represents a promising opportunity for CDMOs. This panel discussion at CPhI Worldwide touched upon some of the opportunities, hurdles, and trends ahead for the CDMO market -
News CPhI Worldwide is back, and this time it’s hybrid
A new in-person and online edition of CPhI Worldwide, transforming your event experience. -
News 5 Highlights from the Pharmapack Europe Content Programme
Pharmapack Europe is back! Join us online from 27 September as we kick off our two-week long content programme, a great precursor to the in-person event from 13-14 October at the Paris Expo Porte de Versailles. -
News Finding the right experts and collaborating at speed essential to COVID-19 vaccine rollout, says CPhI panel
CPhI Discover webinar examines the progress made so far in terms of vaccine distribution to the global population as well as anticipating future challenges -
News UPDATED: The CPhI Discover Blog
Bookmark this page for regular updates on the rich variety of content coming your way via CPhI Discover, pharma’s largest ever virtual gathering, over the course of our three-day agenda -
News COVID-19 has exacerbated contract manufacturing challenges but industry continues to respond well to crisis: experts
Coronavirus pandemic has exacerbated manufacturing capacity constraints, particularly in injectable dose and viral vector production, CPhI audience told -
News APIs, excipients and formulation: the bedrock of medical innovation
Our virtual CPHI Discover event (17th-28th May) is just around the corner, full to the brim with three main content tracks. Here, we explore the major trends in APIs, Ingredients & Formulation
Position your company at the heart of the global Pharma industry with a CPhI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPhI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance